Narrow Results

Infinitus Establishes Three Additional Scientific Research Platforms to Facilitate Its Product Innovation.

BGI Partners with NRGene to Provide Broadest Genomic Analysis Available.

CHINA AID - A Platform for Chinese Senior Care Industry.

Modern Biotechnological Tools Contribute to Biodiversity Conservation.

Older Adults Use Brain Regions Involved in Speaking to Compensate for Bad Hearing.

Chinese Scientists Discover Molecules to Repair Organs.

CAS Sits Atop of Nature Index 2016 Rising Star List.

Chinese Researchers to Develop 3D Skin Printing Technology.

Varian Chosen to Equip First Government Owned Proton Centre in China.

HONG KONG NEWS – Amgen Launches Commercial Office in Hong Kong.

Drug development companies in APAC need to raise their game to capitalise on the $33bn+ immuno-oncology treatment opportunity

Singapore’s pharmaceutical market value to reach $1.15 billion by 2021

Ryzodeg reduces hypoglycaemia in type 2 diabetic fasting patients

FDA approves Amgen’s Repatha (evolocumab) to prevent heart attack and stroke

FDA approves first drug for rare disease, eosinophilic granulomatosis with polyangiitis

FDA approves first biosimilar for the treatment of certain breast and stomach cancers

FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss

Singapore institutes collaborate with Samsung Medical Center to improve treatment of liver cancer

Globavir announces partnership with Singhealth Duke-NUS Academic Medical Centre to study dengue treatment

Mundipharma secures exclusive license for the development and commercialisation of PAION’s remimazolam in Japan

Johnson & Johnson opens new Asia Pacific Headquarters in Singapore.

India’s new guidelines on medical devices will benefit local players in long run.

Duke-NUS and Novo Nordisk to develop stem cell-based therapy for heart and eye diseases.

GE Healthcare and A*STAR co-develop medical technologies for next generation imaging diagnostics and patient monitoring.

Amgen opens next-generation workplace in Singapore.

Novotech says Federal Budget R&D tax support keeps Australia globally competitive for quality clinical trials.

Affordability and functions will determine the success of food 3D printers.

The following topics are under this section:

• Australian medical life sciences company expands nutraceutical business to the USA
• First Amgen Scholars Asia Symposium in Singapore held by Amgen Foundation
• Breakthrough study by world leader in meat-free food finds alternative source of protein to milk protein
• Meeting the need for Surgical Site Infection Prevention in the Asia Pacific
• Patient intelligence company raises US$13 million, taking its AI-powered doctor discovery platform global
• New study reveals top health and nutrition priorities for children, according to Mothers across Asia Pacific
• Entity Health launches new supplement targeted as a defence against progression to Type 2 Diabetes
• Xylonix collaborates with BioGemex to develop novel pre-treatment point-of-care diagnostic
• Imagion Biosystems initiates regulatory communications for first-in-human study